nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—Hypercholesterolaemia—Ibandronate—osteoporosis	0.00507	0.0214	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Calcitriol—osteoporosis	0.00496	0.0209	CcSEcCtD
Tirofiban—Haematuria—Calcium Acetate—osteoporosis	0.0047	0.0198	CcSEcCtD
Tirofiban—Bradycardia—Calcium Acetate—osteoporosis	0.0045	0.019	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Risedronate—osteoporosis	0.00418	0.0176	CcSEcCtD
Tirofiban—Swelling—Ibandronate—osteoporosis	0.00395	0.0167	CcSEcCtD
Tirofiban—Haemoptysis—Estradiol—osteoporosis	0.00357	0.0151	CcSEcCtD
Tirofiban—Oedema—Calcium Acetate—osteoporosis	0.00314	0.0133	CcSEcCtD
Tirofiban—Swelling—Pamidronate—osteoporosis	0.00309	0.013	CcSEcCtD
Tirofiban—Hypertension—Ergocalciferol—osteoporosis	0.00294	0.0124	CcSEcCtD
Tirofiban—Swelling—Zoledronate—osteoporosis	0.00282	0.0119	CcSEcCtD
Tirofiban—Myocardial infarction—Estropipate—osteoporosis	0.00274	0.0116	CcSEcCtD
Tirofiban—Swelling—Conjugated Estrogens—osteoporosis	0.00272	0.0115	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—COL1A1—osteoporosis	0.00272	0.00356	CbGpPWpGaD
Tirofiban—Pain—Calcium Acetate—osteoporosis	0.00269	0.0113	CcSEcCtD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—osteoporosis	0.00267	0.0035	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—COL1A2—osteoporosis	0.00264	0.00346	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—FGB—osteoporosis	0.00262	0.00343	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—COL1A2—osteoporosis	0.00261	0.00342	CbGpPWpGaD
Tirofiban—Sweating—Raloxifene—osteoporosis	0.0026	0.011	CcSEcCtD
Tirofiban—Sweating—Ibandronate—osteoporosis	0.00257	0.0109	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—TLN1—osteoporosis	0.00254	0.00333	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—VCL—osteoporosis	0.00251	0.00329	CbGpPWpGaD
Tirofiban—Haemoglobin—Alendronate—osteoporosis	0.00249	0.0105	CcSEcCtD
Tirofiban—Haemorrhage—Alendronate—osteoporosis	0.00247	0.0104	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—FGA—osteoporosis	0.00247	0.00324	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00242	0.00318	CbGpPWpGaD
Tirofiban—Haemoglobin—Ibandronate—osteoporosis	0.00242	0.0102	CcSEcCtD
Tirofiban—Haemorrhage—Ibandronate—osteoporosis	0.00241	0.0102	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.00239	0.00313	CbGpPWpGaD
Tirofiban—Pain—Ergocalciferol—osteoporosis	0.00237	0.01	CcSEcCtD
Tirofiban—Haemoglobin—Calcitriol—osteoporosis	0.00237	0.01	CcSEcCtD
Tirofiban—Haemorrhage—Calcitriol—osteoporosis	0.00236	0.00995	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.00235	0.00308	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00234	0.00307	CbGpPWpGaD
Tirofiban—Hypersensitivity—Calcium Acetate—osteoporosis	0.00231	0.00977	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—SPP1—osteoporosis	0.00229	0.003	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—SPP1—osteoporosis	0.00228	0.00299	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00228	0.00299	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—RAP1A—osteoporosis	0.00228	0.00298	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—IBSP—osteoporosis	0.00225	0.00295	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—FGB—osteoporosis	0.00225	0.00294	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—IBSP—osteoporosis	0.00224	0.00294	CbGpPWpGaD
Tirofiban—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00222	0.00938	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—FGA—osteoporosis	0.00222	0.00291	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—DKK1—osteoporosis	0.00221	0.00289	CbGpPWpGaD
Tirofiban—Swelling—Estradiol—osteoporosis	0.00218	0.00918	CcSEcCtD
Tirofiban—Chills—Ibandronate—osteoporosis	0.00216	0.00912	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00214	0.0028	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—TLN1—osteoporosis	0.00213	0.00279	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—WNT1—osteoporosis	0.00213	0.00279	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—VCL—osteoporosis	0.0021	0.00275	CbGpPWpGaD
Tirofiban—Dizziness—Calcium Acetate—osteoporosis	0.00208	0.00877	CcSEcCtD
Tirofiban—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00205	0.00863	CcSEcCtD
Tirofiban—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00204	0.00859	CcSEcCtD
Tirofiban—ITGB3—IL4-mediated signaling events—COL1A1—osteoporosis	0.00203	0.00266	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—FGB—osteoporosis	0.00202	0.00264	CbGpPWpGaD
Tirofiban—Haematuria—Pamidronate—osteoporosis	0.002	0.00846	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—COL1A1—osteoporosis	0.002	0.00262	CbGpPWpGaD
Tirofiban—Haemoglobin—Risedronate—osteoporosis	0.00199	0.00842	CcSEcCtD
Tirofiban—Haemorrhage—Risedronate—osteoporosis	0.00198	0.00837	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—FGA—osteoporosis	0.0019	0.00249	CbGpPWpGaD
Tirofiban—Haemoglobin—Pamidronate—osteoporosis	0.0019	0.008	CcSEcCtD
Tirofiban—Haemorrhage—Pamidronate—osteoporosis	0.00189	0.00796	CcSEcCtD
Tirofiban—Nausea—Calcium Acetate—osteoporosis	0.00187	0.00787	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00186	0.00244	CbGpPWpGaD
Tirofiban—Haematuria—Zoledronate—osteoporosis	0.00183	0.00772	CcSEcCtD
Tirofiban—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00181	0.00765	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.00181	0.00237	CbGpPWpGaD
Tirofiban—Hypertension—Ibandronate—osteoporosis	0.00181	0.00764	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.0018	0.00236	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Estropipate—osteoporosis	0.00178	0.00753	CcSEcCtD
Tirofiban—Oedema—Estropipate—osteoporosis	0.00178	0.00753	CcSEcCtD
Tirofiban—Hypertension—Calcitriol—osteoporosis	0.00177	0.00748	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—SPP1—osteoporosis	0.00176	0.00231	CbGpPWpGaD
Tirofiban—Bradycardia—Zoledronate—osteoporosis	0.00175	0.0074	CcSEcCtD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—RAP1A—osteoporosis	0.00175	0.0023	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—LEP—osteoporosis	0.00174	0.00228	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—FGB—osteoporosis	0.00173	0.00227	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—IBSP—osteoporosis	0.00173	0.00226	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—CAP1—osteoporosis	0.00172	0.00226	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Ibandronate—osteoporosis	0.00171	0.00722	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.0017	0.00223	CbGpPWpGaD
Tirofiban—Chills—Pamidronate—osteoporosis	0.00169	0.00714	CcSEcCtD
Tirofiban—Thrombocytopenia—Raloxifene—osteoporosis	0.00169	0.00714	CcSEcCtD
Tirofiban—Anaphylactic shock—Calcitriol—osteoporosis	0.00168	0.00707	CcSEcCtD
Tirofiban—Hyperhidrosis—Raloxifene—osteoporosis	0.00167	0.00705	CcSEcCtD
Tirofiban—Hyperhidrosis—Ibandronate—osteoporosis	0.00165	0.00698	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—TLN1—osteoporosis	0.00165	0.00217	CbGpPWpGaD
Tirofiban—Nausea—Ergocalciferol—osteoporosis	0.00165	0.00696	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00165	0.00216	CbGpPWpGaD
Tirofiban—Urticaria—Etidronic acid—osteoporosis	0.00164	0.00691	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—ACTG1—osteoporosis	0.00163	0.00214	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VCL—osteoporosis	0.00163	0.00214	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—SPP1—osteoporosis	0.00162	0.00213	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—IRS1—osteoporosis	0.00155	0.00203	CbGpPWpGaD
Tirofiban—Chills—Zoledronate—osteoporosis	0.00155	0.00653	CcSEcCtD
Tirofiban—Pain—Estropipate—osteoporosis	0.00153	0.00644	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—WDR1—osteoporosis	0.00153	0.002	CbGpPWpGaD
Tirofiban—Hypersensitivity—Etidronic acid—osteoporosis	0.00152	0.00641	CcSEcCtD
Tirofiban—Pain—Alendronate—osteoporosis	0.0015	0.00634	CcSEcCtD
Tirofiban—Hypertension—Risedronate—osteoporosis	0.00149	0.00629	CcSEcCtD
Tirofiban—Pain—Raloxifene—osteoporosis	0.00148	0.00624	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—RAP1A—osteoporosis	0.00147	0.00192	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.00146	0.00192	CbGpPWpGaD
Tirofiban—Pain—Ibandronate—osteoporosis	0.00146	0.00617	CcSEcCtD
Tirofiban—Myocardial infarction—Estradiol—osteoporosis	0.00145	0.00612	CcSEcCtD
Tirofiban—Oedema—Ethinyl Estradiol—osteoporosis	0.00145	0.0061	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00144	0.00189	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—COL1A2—osteoporosis	0.00144	0.00189	CbGpPWpGaD
Tirofiban—Pain—Calcitriol—osteoporosis	0.00143	0.00604	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00143	0.00188	CbGpPWpGaD
Tirofiban—ITGB3—Syndecan interactions—TGFB1—osteoporosis	0.00142	0.00187	CbGpPWpGaD
Tirofiban—Hypertension—Pamidronate—osteoporosis	0.00142	0.00598	CcSEcCtD
Tirofiban—Urticaria—Estropipate—osteoporosis	0.00142	0.00598	CcSEcCtD
Tirofiban—Haematuria—Estradiol—osteoporosis	0.00141	0.00595	CcSEcCtD
Tirofiban—Body temperature increased—Estropipate—osteoporosis	0.00141	0.00595	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—COL1A2—osteoporosis	0.0014	0.00183	CbGpPWpGaD
Tirofiban—Urticaria—Alendronate—osteoporosis	0.0014	0.00589	CcSEcCtD
Tirofiban—Body temperature increased—Alendronate—osteoporosis	0.00139	0.00586	CcSEcCtD
Tirofiban—Body temperature increased—Raloxifene—osteoporosis	0.00137	0.00577	CcSEcCtD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.00137	0.00179	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—RAP1A—osteoporosis	0.00136	0.00179	CbGpPWpGaD
Tirofiban—Urticaria—Ibandronate—osteoporosis	0.00136	0.00574	CcSEcCtD
Tirofiban—Body temperature increased—Ibandronate—osteoporosis	0.00135	0.00571	CcSEcCtD
Tirofiban—Oedema—Pamidronate—osteoporosis	0.00134	0.00566	CcSEcCtD
Tirofiban—Anaphylactic shock—Pamidronate—osteoporosis	0.00134	0.00566	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—LEP—osteoporosis	0.00134	0.00175	CbGpPWpGaD
Tirofiban—Haemoglobin—Estradiol—osteoporosis	0.00133	0.00563	CcSEcCtD
Tirofiban—Urticaria—Calcitriol—osteoporosis	0.00133	0.00561	CcSEcCtD
Tirofiban—Haemorrhage—Estradiol—osteoporosis	0.00133	0.0056	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—CAP1—osteoporosis	0.00133	0.00174	CbGpPWpGaD
Tirofiban—Body temperature increased—Calcitriol—osteoporosis	0.00132	0.00559	CcSEcCtD
Tirofiban—Hypersensitivity—Estropipate—osteoporosis	0.00131	0.00555	CcSEcCtD
Tirofiban—Thrombocytopenia—Pamidronate—osteoporosis	0.00131	0.00554	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00131	0.00172	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—SPP1—osteoporosis	0.0013	0.0017	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Pamidronate—osteoporosis	0.0013	0.00547	CcSEcCtD
Tirofiban—Hypertension—Zoledronate—osteoporosis	0.0013	0.00547	CcSEcCtD
Tirofiban—Hypersensitivity—Alendronate—osteoporosis	0.00129	0.00546	CcSEcCtD
Tirofiban—Headache—Etidronic acid—osteoporosis	0.00129	0.00545	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—TLN1—osteoporosis	0.00127	0.00167	CbGpPWpGaD
Tirofiban—Hypersensitivity—Ibandronate—osteoporosis	0.00126	0.00532	CcSEcCtD
Tirofiban—ITGB3—Monoamine Transport—IL1B—osteoporosis	0.00126	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—ACTG1—osteoporosis	0.00126	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VCL—osteoporosis	0.00126	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—SPP1—osteoporosis	0.00125	0.00164	CbGpPWpGaD
Tirofiban—Hypersensitivity—Calcitriol—osteoporosis	0.00123	0.00521	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—CAP1—osteoporosis	0.00123	0.00161	CbGpPWpGaD
Tirofiban—Nausea—Etidronic acid—osteoporosis	0.00123	0.00517	CcSEcCtD
Tirofiban—Oedema—Zoledronate—osteoporosis	0.00122	0.00517	CcSEcCtD
Tirofiban—Anaphylactic shock—Zoledronate—osteoporosis	0.00122	0.00517	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00121	0.00158	CbGpPWpGaD
Tirofiban—Pain—Risedronate—osteoporosis	0.00121	0.00509	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—CAP1—osteoporosis	0.00121	0.00158	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Zoledronate—osteoporosis	0.0012	0.00506	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—IRS1—osteoporosis	0.00119	0.00156	CbGpPWpGaD
Tirofiban—Chills—Estradiol—osteoporosis	0.00119	0.00503	CcSEcCtD
Tirofiban—ITGB3—IL4-mediated signaling events—IRS2—osteoporosis	0.00119	0.00156	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Zoledronate—osteoporosis	0.00118	0.00499	CcSEcCtD
Tirofiban—Dizziness—Estropipate—osteoporosis	0.00118	0.00498	CcSEcCtD
Tirofiban—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00118	0.00497	CcSEcCtD
Tirofiban—Oedema—Conjugated Estrogens—osteoporosis	0.00118	0.00497	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—WDR1—osteoporosis	0.00117	0.00154	CbGpPWpGaD
Tirofiban—Dizziness—Alendronate—osteoporosis	0.00116	0.0049	CcSEcCtD
Tirofiban—Urticaria—Ethinyl Estradiol—osteoporosis	0.00115	0.00485	CcSEcCtD
Tirofiban—Pain—Pamidronate—osteoporosis	0.00115	0.00484	CcSEcCtD
Tirofiban—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00114	0.00482	CcSEcCtD
Tirofiban—Dizziness—Raloxifene—osteoporosis	0.00114	0.00482	CcSEcCtD
Tirofiban—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00114	0.00481	CcSEcCtD
Tirofiban—Dizziness—Ibandronate—osteoporosis	0.00113	0.00477	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.00113	0.00148	CbGpPWpGaD
Tirofiban—Urticaria—Risedronate—osteoporosis	0.00112	0.00473	CcSEcCtD
Tirofiban—Headache—Estropipate—osteoporosis	0.00112	0.00472	CcSEcCtD
Tirofiban—Body temperature increased—Risedronate—osteoporosis	0.00111	0.0047	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00111	0.00146	CbGpPWpGaD
Tirofiban—Headache—Alendronate—osteoporosis	0.0011	0.00465	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—P4HB—osteoporosis	0.0011	0.00144	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.0011	0.00144	CbGpPWpGaD
Tirofiban—Headache—Raloxifene—osteoporosis	0.00108	0.00457	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—TLN1—osteoporosis	0.00108	0.00141	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—COL1A2—osteoporosis	0.00108	0.00141	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—COL1A2—osteoporosis	0.00108	0.00141	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—COL1A1—osteoporosis	0.00108	0.00141	CbGpPWpGaD
Tirofiban—Headache—Ibandronate—osteoporosis	0.00107	0.00452	CcSEcCtD
Tirofiban—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00107	0.0045	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ACTG1—osteoporosis	0.00106	0.00139	CbGpPWpGaD
Tirofiban—Nausea—Estropipate—osteoporosis	0.00106	0.00447	CcSEcCtD
Tirofiban—Body temperature increased—Pamidronate—osteoporosis	0.00106	0.00447	CcSEcCtD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.00105	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—RAP1A—osteoporosis	0.00105	0.00138	CbGpPWpGaD
Tirofiban—Headache—Calcitriol—osteoporosis	0.00105	0.00443	CcSEcCtD
Tirofiban—Pain—Zoledronate—osteoporosis	0.00105	0.00442	CcSEcCtD
Tirofiban—Nausea—Alendronate—osteoporosis	0.00104	0.0044	CcSEcCtD
Tirofiban—Hypersensitivity—Risedronate—osteoporosis	0.00104	0.00438	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—CTSK—osteoporosis	0.00104	0.00136	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IRS1—osteoporosis	0.00104	0.00136	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB1—osteoporosis	0.00103	0.00135	CbGpPWpGaD
Tirofiban—Nausea—Raloxifene—osteoporosis	0.00103	0.00433	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—IRS1—osteoporosis	0.00102	0.00134	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—IGF1—osteoporosis	0.00102	0.00133	CbGpPWpGaD
Tirofiban—Nausea—Ibandronate—osteoporosis	0.00102	0.00429	CcSEcCtD
Tirofiban—Pain—Conjugated Estrogens—osteoporosis	0.00101	0.00425	CcSEcCtD
Tirofiban—Hypertension—Estradiol—osteoporosis	0.000998	0.00421	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000996	0.00131	CbGpPWpGaD
Tirofiban—Nausea—Calcitriol—osteoporosis	0.000995	0.0042	CcSEcCtD
Tirofiban—Hypersensitivity—Pamidronate—osteoporosis	0.000988	0.00417	CcSEcCtD
Tirofiban—Urticaria—Zoledronate—osteoporosis	0.000973	0.0041	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000969	0.00127	CbGpPWpGaD
Tirofiban—Body temperature increased—Zoledronate—osteoporosis	0.000968	0.00408	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—MGLL—osteoporosis	0.000958	0.00126	CbGpPWpGaD
Tirofiban—Dizziness—Ethinyl Estradiol—osteoporosis	0.000956	0.00404	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—FGA—osteoporosis	0.00095	0.00124	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—IGF1—osteoporosis	0.000948	0.00124	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CAP1—osteoporosis	0.000947	0.00124	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Estradiol—osteoporosis	0.000944	0.00398	CcSEcCtD
Tirofiban—Oedema—Estradiol—osteoporosis	0.000944	0.00398	CcSEcCtD
Tirofiban—Urticaria—Conjugated Estrogens—osteoporosis	0.000937	0.00395	CcSEcCtD
Tirofiban—Dizziness—Risedronate—osteoporosis	0.000933	0.00393	CcSEcCtD
Tirofiban—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000932	0.00393	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00093	0.00122	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CAP1—osteoporosis	0.000929	0.00122	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TNF—osteoporosis	0.000913	0.0012	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Estradiol—osteoporosis	0.000912	0.00385	CcSEcCtD
Tirofiban—Headache—Ethinyl Estradiol—osteoporosis	0.000906	0.00382	CcSEcCtD
Tirofiban—Hypersensitivity—Zoledronate—osteoporosis	0.000902	0.00381	CcSEcCtD
Tirofiban—Dizziness—Pamidronate—osteoporosis	0.000886	0.00374	CcSEcCtD
Tirofiban—Headache—Risedronate—osteoporosis	0.000883	0.00373	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—BMP2—osteoporosis	0.000883	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ANXA2—osteoporosis	0.000876	0.00115	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PLEK—osteoporosis	0.000876	0.00115	CbGpPWpGaD
Tirofiban—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000869	0.00367	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—FGB—osteoporosis	0.000864	0.00113	CbGpPWpGaD
Tirofiban—Nausea—Ethinyl Estradiol—osteoporosis	0.000859	0.00362	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—P4HB—osteoporosis	0.000844	0.00111	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000844	0.00111	CbGpPWpGaD
Tirofiban—Headache—Pamidronate—osteoporosis	0.00084	0.00354	CcSEcCtD
Tirofiban—Nausea—Risedronate—osteoporosis	0.000838	0.00353	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—TLN1—osteoporosis	0.000831	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—COL1A2—osteoporosis	0.000828	0.00109	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—COL1A1—osteoporosis	0.000828	0.00109	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—COL1A1—osteoporosis	0.000826	0.00108	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB1—osteoporosis	0.000823	0.00108	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ACTG1—osteoporosis	0.00082	0.00107	CbGpPWpGaD
Tirofiban—Dizziness—Zoledronate—osteoporosis	0.00081	0.00342	CcSEcCtD
Tirofiban—Pain—Estradiol—osteoporosis	0.000807	0.0034	CcSEcCtD
Tirofiban—ITGB3—Elastic fibre formation—TGFB1—osteoporosis	0.000802	0.00105	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—CTSK—osteoporosis	0.0008	0.00105	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.0008	0.00105	CbGpPWpGaD
Tirofiban—Nausea—Pamidronate—osteoporosis	0.000796	0.00336	CcSEcCtD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—osteoporosis	0.000786	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—TGFB1—osteoporosis	0.000786	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—IGF1—osteoporosis	0.000783	0.00103	CbGpPWpGaD
Tirofiban—Dizziness—Conjugated Estrogens—osteoporosis	0.00078	0.00329	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—TLN1—osteoporosis	0.00077	0.00101	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000767	0.00101	CbGpPWpGaD
Tirofiban—Headache—Zoledronate—osteoporosis	0.000767	0.00324	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ACTG1—osteoporosis	0.000759	0.000995	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TLN1—osteoporosis	0.000755	0.000989	CbGpPWpGaD
Tirofiban—Urticaria—Estradiol—osteoporosis	0.00075	0.00316	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000746	0.000978	CbGpPWpGaD
Tirofiban—Body temperature increased—Estradiol—osteoporosis	0.000746	0.00315	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—VCL—osteoporosis	0.000745	0.000976	CbGpPWpGaD
Tirofiban—Headache—Conjugated Estrogens—osteoporosis	0.000739	0.00312	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—MGLL—osteoporosis	0.000738	0.000967	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—FGA—osteoporosis	0.000732	0.000959	CbGpPWpGaD
Tirofiban—Nausea—Zoledronate—osteoporosis	0.000727	0.00307	CcSEcCtD
Tirofiban—Nausea—Conjugated Estrogens—osteoporosis	0.0007	0.00296	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—SPP1—osteoporosis	0.000696	0.000912	CbGpPWpGaD
Tirofiban—Hypersensitivity—Estradiol—osteoporosis	0.000695	0.00293	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—BMP2—osteoporosis	0.00068	0.000892	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ANXA2—osteoporosis	0.000675	0.000884	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PLEK—osteoporosis	0.000675	0.000884	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—FGB—osteoporosis	0.000666	0.000872	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—COL1A1—osteoporosis	0.000637	0.000834	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—TGFB1—osteoporosis	0.000634	0.000831	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6R—osteoporosis	0.00063	0.000825	CbGpPWpGaD
Tirofiban—Dizziness—Estradiol—osteoporosis	0.000624	0.00263	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—RAP1A—osteoporosis	0.000622	0.000816	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.000616	0.000808	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—TGFB1—osteoporosis	0.00061	0.000799	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6R—osteoporosis	0.000594	0.000779	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TLN1—osteoporosis	0.000593	0.000777	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—WNT1—osteoporosis	0.000591	0.000775	CbGpPWpGaD
Tirofiban—Headache—Estradiol—osteoporosis	0.000591	0.00249	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—ACTG1—osteoporosis	0.000585	0.000767	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TLN1—osteoporosis	0.000582	0.000762	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000581	0.000761	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VCL—osteoporosis	0.000574	0.000752	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—FGA—osteoporosis	0.000564	0.00074	CbGpPWpGaD
Tirofiban—Nausea—Estradiol—osteoporosis	0.000561	0.00236	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—SPP1—osteoporosis	0.000536	0.000703	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—SPP1—osteoporosis	0.000535	0.000701	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—FGB—osteoporosis	0.000514	0.000673	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—osteoporosis	0.000511	0.00067	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—IGF1—osteoporosis	0.000509	0.000667	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—RAP1A—osteoporosis	0.000479	0.000628	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—TGFB1—osteoporosis	0.00047	0.000615	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—WNT1—osteoporosis	0.000456	0.000597	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SOST—osteoporosis	0.000452	0.000592	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000451	0.000591	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000447	0.000586	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—FGA—osteoporosis	0.000435	0.00057	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—SPP1—osteoporosis	0.000412	0.00054	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CALCR—osteoporosis	0.000409	0.000536	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTH1R—osteoporosis	0.000409	0.000536	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—FGB—osteoporosis	0.000396	0.000518	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—IGF1—osteoporosis	0.000392	0.000514	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SOST—osteoporosis	0.000348	0.000456	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000347	0.000455	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6R—osteoporosis	0.000337	0.000441	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000329	0.000432	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MGLL—osteoporosis	0.000325	0.000426	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LRP5—osteoporosis	0.000317	0.000415	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—osteoporosis	0.000315	0.000413	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCR—osteoporosis	0.000315	0.000413	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTH1R—osteoporosis	0.000315	0.000413	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TGFB1—osteoporosis	0.000315	0.000412	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LRP6—osteoporosis	0.000303	0.000397	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—LEP—osteoporosis	0.000287	0.000376	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—osteoporosis	0.00028	0.000368	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.00027	0.000354	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6—osteoporosis	0.000265	0.000347	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6R—osteoporosis	0.000259	0.00034	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TLN1—osteoporosis	0.000256	0.000335	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MGLL—osteoporosis	0.00025	0.000328	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LRP5—osteoporosis	0.000244	0.00032	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6R—osteoporosis	0.00024	0.000315	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB1—osteoporosis	0.000235	0.000307	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LRP6—osteoporosis	0.000233	0.000306	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IGF1—osteoporosis	0.000232	0.000305	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—LEP—osteoporosis	0.000221	0.00029	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—P4HB—osteoporosis	0.000221	0.000289	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTH—osteoporosis	0.000215	0.000281	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAP1A—osteoporosis	0.000211	0.000277	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CNR2—osteoporosis	0.000209	0.000274	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000208	0.000273	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NFATC1—osteoporosis	0.000206	0.00027	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—DKK1—osteoporosis	0.000204	0.000268	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TLN1—osteoporosis	0.000197	0.000258	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—WNT1—osteoporosis	0.000197	0.000258	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGA—osteoporosis	0.000191	0.000251	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6R—osteoporosis	0.000185	0.000243	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB1—osteoporosis	0.000181	0.000237	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IGF1—osteoporosis	0.000179	0.000235	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTHLH—osteoporosis	0.000178	0.000233	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BMP2—osteoporosis	0.000178	0.000233	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGB—osteoporosis	0.000174	0.000228	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—P4HB—osteoporosis	0.00017	0.000223	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PSMA2—osteoporosis	0.000168	0.00022	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PSMA5—osteoporosis	0.000168	0.00022	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTH—osteoporosis	0.000165	0.000217	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAP1A—osteoporosis	0.000163	0.000213	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CNR2—osteoporosis	0.000161	0.000211	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NFATC1—osteoporosis	0.000159	0.000208	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—DKK1—osteoporosis	0.000157	0.000206	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CALCA—osteoporosis	0.000157	0.000205	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—WNT1—osteoporosis	0.000152	0.000199	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—osteoporosis	0.00015	0.000197	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGA—osteoporosis	0.000147	0.000193	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KL—osteoporosis	0.000142	0.000186	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—osteoporosis	0.000142	0.000186	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—osteoporosis	0.000139	0.000183	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTHLH—osteoporosis	0.000137	0.00018	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BMP2—osteoporosis	0.000137	0.00018	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGB—osteoporosis	0.000134	0.000176	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—osteoporosis	0.000133	0.000174	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PSMA2—osteoporosis	0.000129	0.00017	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PSMA5—osteoporosis	0.000129	0.00017	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCA—osteoporosis	0.000121	0.000158	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—osteoporosis	0.000116	0.000151	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADCY5—osteoporosis	0.000111	0.000146	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KL—osteoporosis	0.00011	0.000144	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—osteoporosis	0.000109	0.000143	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SPP1—osteoporosis	0.000108	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—osteoporosis	0.000107	0.000141	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—osteoporosis	0.000107	0.00014	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—osteoporosis	0.000102	0.000134	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IRS2—osteoporosis	9.75e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LEP—osteoporosis	9.54e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—osteoporosis	9.11e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADCY5—osteoporosis	8.58e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IRS1—osteoporosis	8.51e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SPP1—osteoporosis	8.3e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—osteoporosis	8.25e-05	0.000108	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—POMC—osteoporosis	8.19e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6R—osteoporosis	7.99e-05	0.000105	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1—osteoporosis	7.88e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IRS2—osteoporosis	7.51e-05	9.84e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LEP—osteoporosis	7.35e-05	9.63e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—osteoporosis	7.02e-05	9.19e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IRS1—osteoporosis	6.56e-05	8.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—POMC—osteoporosis	6.31e-05	8.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6R—osteoporosis	6.16e-05	8.07e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1—osteoporosis	6.07e-05	7.96e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—osteoporosis	4.74e-05	6.21e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—osteoporosis	4.73e-05	6.19e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—osteoporosis	3.65e-05	4.78e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—osteoporosis	3.64e-05	4.77e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—osteoporosis	3.56e-05	4.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—osteoporosis	2.74e-05	3.6e-05	CbGpPWpGaD
